EP0906085A1 - Compositions - Google Patents

Compositions

Info

Publication number
EP0906085A1
EP0906085A1 EP97927895A EP97927895A EP0906085A1 EP 0906085 A1 EP0906085 A1 EP 0906085A1 EP 97927895 A EP97927895 A EP 97927895A EP 97927895 A EP97927895 A EP 97927895A EP 0906085 A1 EP0906085 A1 EP 0906085A1
Authority
EP
European Patent Office
Prior art keywords
oral hygiene
composition
hygiene composition
polyvinyl pyrrolidone
stannous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97927895A
Other languages
German (de)
English (en)
Other versions
EP0906085A4 (fr
Inventor
Roger Lidderdale Scarlett-Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0906085A1 publication Critical patent/EP0906085A1/fr
Publication of EP0906085A4 publication Critical patent/EP0906085A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers

Definitions

  • the present invention relates to oral hygiene compositions comprising a stannous salt and an anti-staining agent, for use in treating or preventing dental plaque, caries, or periodontal diseases of the oral cavity in humans or lower animals with reduced staining of teeth.
  • PVP polyvinylpyrroiidone
  • This material is already used in some toothpastes at comparatively low levels (typically about 0.1%) as an auxiliary thickening agent and foam enhancer.
  • PVP may be used in oral hygiene compositions, for the prevention of stains associated with the use of chlorophyll in such compositions (GB 739 936, Colgate-Palmolive Co) and also in the removal of stains, in particular tobacco tar stains, from tooth surfaces (GB 741 315, Colgate-Palmolive-Peet Co).
  • WO 9316681 describes the use of PVP to counter the staining associated with the use of cationic antibacterial agents such as chlorhexidine.
  • the present invention provides an oral hygiene composition
  • a bacteriostatic effective amount of a stannous salt an anti-stain effective amount of polyvinyl pyrrolidone and an orally acceptable carrier or excipient.
  • Polyvinyl pyrrolidone for use in the present invention suitably has an average molecular weight in the range 5,000 to 100,000, preferably in the range 5,000 to 50,000.
  • Polyvinyl pyrrolidones which have average molecular weights of 10,000, . 30,000 and 40,000 are available from Sigma Chemjeal Co., GAF Corporation and Sigma Chemical Co. respectively.
  • Polyvinyl pyrrolidone is suitably present in at least
  • Suitable stannous salts for use in the present invention include stannous fluoride, stannous chloride, stannous pyrophosphate and stannous chlorofluoride and mixtures thereof.
  • the stannous salt is present in from 0.005 to 10% preferably 0.01 to 5%, more preferably 0.01 to 2%, by weight of the oral hygiene composition.
  • Oral hygiene compositions of the present invention may also usefully contain an ionic fluorine-containing compound.
  • Suitable ionic fluorine-containing compounds include, for instance, fluoride salts such as amine fluorides and alkali metal fluoride salts, for example sodium fluoride, and monofluorophosphate salts such as alkali metal monofluorophosphate salts, for example sodium monofluorophosphate.
  • fluoride salts such as amine fluorides and alkali metal fluoride salts, for example sodium fluoride
  • monofluorophosphate salts such as alkali metal monofluorophosphate salts, for example sodium monofluorophosphate.
  • the ionic fluorine-containing compound is incorporated into the composition to provide between 100 and 3000ppm, preferably between 500 and 2000ppm of fluoride ions.
  • Oral hygiene compositions of the present invention maybe provided in any of the presentations normally used for such products, for instance, dentifrices including toothpastes and toothpowders, abrasive and non-abrasive gels, mouthwashes, gargles, irrigating solutions, mouthsprays and presentations for sucking or chewing by the user such as gums, pastilles and lozenges.
  • Components for the orally acceptable carrier or excipient will be selected according to the particular type of presentation involved. It will be appreciated by those skilled in the art that in order to ensure that the antibacterial efficacy of the stannous salt is not substantially diminished, compatible components will be selected for inclusion in the orally acceptable carrier or excipient.
  • compositions comprising a stannous salt are described in WO 9307850, WO 9403147 and WO 9509602.
  • Suitable nonionic surfactants include, for example, polyethoxylated sorbitol esters, in particular polyethoxylated sorbitol monoesters, for instance, PEG(40) sorbitan di-isostearate, and the products marketed under the trade name 'Tween' by ICI; polycondensates of ethylene oxide and propylene oxide (poloxamers), for instance the products marketed under the trade name 'Pluronic' by BASF-Wyandotte; condensates of propylene glycol; polyethoxylated hydrogenated castor oil, for instance, cremophors; and sorbitan fatty esters.
  • polyethoxylated sorbitol esters in particular polyethoxylated sorbitol monoesters, for instance, PEG(40) sorbitan di-isostearate, and the products marketed under the trade name 'Tween' by ICI
  • Suitable amphoteric surfactants include, for example, long chain imidazoline derivatives such as the product marketed under the trade name 'Miranol C2M' by Miranol; long chain alkyl betaines, such as the product marketed under the tradename 'Empigen BB' by Albright + Wilson, and long chain alkyl amidoalkyl betaines, such as cocamidopropylbetaine, and mixtures thereof.
  • Suitable cationic surfactants include the D,L-2-pyrrolidone-5-carboxylic acid salt of ethyl-N-cocoyl-L-arginate, marketed under the trade name CAE by Ajinomoto Co. Inc.
  • the surfactant is present in the range 0.005 to 20%, preferably 0.1 to 10%, more preferably 0.1 to 5% by weight of the dentifrice.
  • Suitable nonionic thickening agents include, for example, (Cj-g)- alkylcellulose ethers, for instance methylcellutose, hydroxy(C ⁇ -6)-alkylcellulose ethers, for instance hydroxypropylcellulose, (C2"6)-alkylene oxide modified (Cj- ⁇ )- alkylcellulose ethers, for instance hydroxypropyl methylcellulose, and mixtures thereof.
  • the nonionic thickening agent is present in the range 0.01 to
  • composition 30%, preferably 0.1 to 15%, more preferbly 1 to 5%, by weight of the composition.
  • Suitable sparingly soluble salts that may be used as an abrasive include calcium carbonate, calcium phosphates, magnesium carbonate, insoluble sodium metaphosphate, and suitable mixtures thereof.
  • the agent to suppress anion formation typically comprises a water soluble salt containing a cation which may be same as the cation of the abrasive and which forms an essentially insoluble or sparingly soluble
  • the sparingly soluble salt used as an abrasive is calcium carbonate, advantageously used in combination with dicalcium phosphate, which also usefully buffers the pH of the formulation. Suitable types of calcium carbonate include both natural and synthetic chalks.
  • the agent to suppress anion formation may be an alkaline earth metal salt, for instance calcium chloride.
  • the agent is preferably present in from 0.0001 to 1%, more preferably 0.005 to 0.1 % by weight of the dentifrice.
  • the term 'essentially insoluble compound' as used herein refers to a compound which is intrinsically insoluble in aqueous solution and includes those compounds which are listed as being 'insoluble' in cold water in the 'Handbook of Chemistry and Physics', 48th Edition, Chemical Rubber Company, Section B, Physical Constants of Inorganic Compounds. Furthermore, such compounds when used as an abrasive shall contain little if any contaminating anionic impurities.
  • the insoluble abrasive compound should contains less than 1%, preferably less than 0.5%, and more preferably less than 0.25% of anionic impurities, based on the weight of the abrasive.
  • Suitable essentially insoluble compounds for use as abrasives include, for example, silica, zinc orthophosphate, plastics particles, alumina, hydrated alumina, and calcium pyrophosphate or mixtures thereof.
  • the abrasive is silica.
  • Suitable silicas include natural amorphous silica, for instance diatomaceous earth; and synthetic amorphous silicas, for instance a precipitated silica, or a silica gel, such as a silica xerbgel; or mixtures thereof.
  • the preferred synthetic amorphous silicas are those with a low-level of water soluble anionic impurities (hereinafter referred to as "low-anion silica"). These are obtainable from manufacturing process which are carefully controlled so that the level of anion impurities, particularly sulphate and silicate from sodium sulphate and sodium silicate, respectively, is kept to a minimum.
  • the level of anion impurities may be reduced to the required level by careful washing of the initially produced silica with, for instance, deionised or distilled water.
  • Suitable low- anion silicas contain less than 0.5%, preferably less than 0.25%, more preferably less than 0.1% by weight of water soluble impurities such as sodium sulphate and/or sodium silicate. Examples of such low-anion silicas are described in EP A 0 315 503 (to Rhone-Poulenc). Suitable silica xerogels are described in US 3 538 230.
  • Preferred precipitated silicas include the grade RP93 available from Rhone-Poulenc and those marketed under the trade name 'SIDENT' by Degussa, for instance, SIDENT 9 silica.
  • Preferred silica xerogels are those marketed under the trade name 'SYLOBLANC by W.R. Grace Corporation, Davison Chemical Division.
  • Suitable grades of precipitated silica have BET surface areas in the range 20 to 300, preferably 20 to 100 m ⁇ /g and median agglomerate sizes in the range 2 to 50, preferably 5 to 30 ⁇ m.
  • Suitable forms of diatomaceous earth include those marketed under the trade name 'Celite' by Johns-Manville Products Corporation, for instance 'Celite Superfine Superfloss'.
  • the abrasive is advantageously present in the range 1 to 80%, preferably 5 to 70%, more preferably 5 to60% by weight of the dentifrice.
  • each of the thickening agent, the surfactant and abrasive should be, at the level employed in the dentifrice, compatible with the stannous salt, that is, each will not substantially reduce the availability of the stannous salt, for instance, by more than 30%, preferably more than 20%. This may be confirmed by, for instance, determining the biological activity of the formulation, by conventional microbiological assay using, for instance, M. luteus as the assay organism in a standard agar diffusion method, in the presence and absence of each of the aforementioned thickening agent, surfactant and abrasive.
  • Mouthwashes according to the present invention will preferably comprise as components of the carrier a surfactant and a humectant in an aqueous or an aqueous/ethanol solution.
  • Gels according to the present invention will preferably comprise as components of the carrier a surfactant, humectant, thickening agent and optionally water.
  • Dentifrices according to the present invention will preferably comprise as components of the carrier a surfactant, humectant, thickening agent, abrasive and if necessary, water.
  • Suitable humectants for use in compositions of the invention include for instance glycerine, sorbitol, propylene glycol or polyethylene glycol, or mixtures thereof.
  • the humectant may be present in the range from 5 to 70%, preferably 5 to 30%, more preferably 10 to 30% by weight of the dentifrice.
  • compositions may be added to the compositions if required, for instance sweetening agents, flavouring agents, colouring and whitening agents, preservatives and emulsifiers.
  • the pH of a composition according to the invention will be orally acceptable and typically in the range pH 5 to 9.
  • Oral hygiene compositions according to the present invention may be prepared by mixing the ingredients thereof in the required proportions and in any order that is convenient and thereafter and if necessary adjusting the pH to the required value.
  • Oral hygiene compositions according to the present invention are of use in reducing or eliminating the stain normally associateed with the use of a bacteriostatic stannous salt. Accordingly, in a further aspect, the present invention provides for an oral hygiene composition as hereinbefore defined for use in therapy, in particular anti- plaque, anti-caries, anti-calculus and/or periodontal (including anti-gingivitis) therapy. The present invention also provides for the use of polyvinyl pyrrolidone and a stannous salt in the manufacture of an oral hygiene composition for use in oral hygiene.
  • the stannous salt and the polyvinyl pyrrolidone anti-stain agent will normally be incorporated together in a single oral hygiene composition.
  • the stannous salt and the polyvinyl pyrrolidone anti-stain agent may however be also provided in separate oral hygiene compositions which may be used separately, simultaneously or sequentially.
  • the present invention provides an oral hygiene kit comprising as a first item an oral hygiene composition comprising an anti-stain effective amount of polyvinyl pyrrolidone and an orally acceptable excipient or carrier and, as a separate second item, an oral hygiene composition comprising a bacteriostatic effective amount of a stannous salt and an orally acceptable excipient or carrier.
  • the two oral hygiene compositions may be of the same or different character.
  • the stannous salt may be provided in a dentifrice whilst polyvinylpyrrolidone is provided in a mouthwash or gargle or vice versa.
  • both may be provided as, for example, a dentifrice, mouthwash or gargle.
  • the present application further provides an oral hygiene composition comprising an antistain effective amount of polyvinyl pyrrolidone and-an orally acceptable excipient or carrier.
  • PVP polyvinylpyrrolidone
  • the colour of a HA disc was measured using a chromameter to establish a baseline figure.
  • the disc was then rinsed with deionised water for 1 min and incubated in pooled filtered human saliva for 2 hour at 37°C, to induce pellicle formation. After further rinsing for 1 min with deionised water, the disc was immersed for 2 min in a solution containing stannous fluoride (0.4% w/v)), after which the disc was rinsed with deionised water (1 minute) and then immersed in cold tea for 3 hr.
  • the disc was then rinsed with deionised water for 1 min, immersed in pooled filtered human saliva for 1 hr at 37°C, rinsed with deionised water for 1 min, subjected to a 2 min application of stannous fluoride (0.4% w/v), rinsed with deionised water for 1 min and then immersed in cold tea overnight.
  • the procedure was repeated daily for 5 days.
  • the colour of the disc was determined using the chromameter.
  • the degree of colour change was calculated using the formula: in whichE* ab is colour difference L is degree of black/white colour a is degree of green/red colour b is degree of blue/yellow colour. In each treatment group, 4 discs were used.
  • Deionised water qs a Methocel K15M premium and Methocel K100LV premium in ratio 1 :4.
  • Example 3 toothpaste Glycerine 10.00%
  • Titanium dioxide 1.00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Cette invention décrit des compositions pour l'hygiène bucco-dentaire comprenant un sel stanneux et un polyvinylpyrrolidone. Ces compositions servent à combattre la coloration associée à l'usage d'un sel stanneux.
EP97927895A 1996-05-31 1997-05-30 Compositions Withdrawn EP0906085A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9611365 1996-05-31
GBGB9611365.9A GB9611365D0 (en) 1996-05-31 1996-05-31 Compositions
PCT/US1997/009409 WO1997045096A1 (fr) 1996-05-31 1997-05-30 Compositions

Publications (2)

Publication Number Publication Date
EP0906085A1 true EP0906085A1 (fr) 1999-04-07
EP0906085A4 EP0906085A4 (fr) 2001-08-22

Family

ID=10794566

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97927895A Withdrawn EP0906085A4 (fr) 1996-05-31 1997-05-30 Compositions

Country Status (3)

Country Link
EP (1) EP0906085A4 (fr)
GB (1) GB9611365D0 (fr)
WO (1) WO1997045096A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475469B1 (en) * 1996-11-21 2002-11-05 Applied Dental Sciences, Inc. Compositions for removing tooth stains
AU9300998A (en) * 1997-09-09 1999-03-29 Smithkline Beecham Corporation Tooth whitening preparations
WO2016100802A1 (fr) * 2014-12-18 2016-06-23 Colgate-Palmolive Company Formulations d'eau dentaire

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892843A (en) * 1973-08-13 1975-07-01 Joseph C Muhler Prophylactic dental compositions
US3925543A (en) * 1973-11-01 1975-12-09 Colgate Palmolive Co Antibacterial oral compositions containing preservative-antioxidants
US4198394A (en) * 1978-07-25 1980-04-15 Faunce Frank R Sodium dihydrogen phosphate enhanced dentifrice composition
JPS5846483B2 (ja) * 1979-09-20 1983-10-17 ライオン株式会社 口腔用組成物
JPS5835965B2 (ja) * 1979-07-31 1983-08-05 ライオン株式会社 口腔用組成物
US4592487A (en) * 1985-07-03 1986-06-03 Simon Gilbert I Dentifrices
US5578293A (en) * 1994-12-06 1996-11-26 Colgate Palmolive Company Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
US5487906A (en) * 1994-12-15 1996-01-30 Colgate-Palmolive Company Method of forming stable aqueous solutions of stannous compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9745096A1 *

Also Published As

Publication number Publication date
EP0906085A4 (fr) 2001-08-22
WO1997045096A1 (fr) 1997-12-04
GB9611365D0 (en) 1996-08-07

Similar Documents

Publication Publication Date Title
US4902497A (en) Oral compositions
EP0670711B1 (fr) Compositions d'hygiene buccale antifongiques
EP0796082B1 (fr) Preparations pour soins bucco-dentaires contenant des composes stanniques stabilises
CA2169460C (fr) Compositions orales renfermant des composes stanneux
EP0548246B1 (fr) Pate dentifrice antimicrobienne
EP0617608B1 (fr) Compositions dentrifices
EP0390456A2 (fr) Composition orale pour le traitement de l'hypersensibilité
EP0626843B1 (fr) Utilisation de la polyvinylpyrrolidone pour reduire l'adherence des bacteries buccales
CA2140874C (fr) Compositions orales
AU665237B2 (en) Compositions
EP0697855A1 (fr) Compositions orales
US20010031245A1 (en) Compositions
EP0644751B1 (fr) Collutoire pour traiter l'hypersensibilite de la dentine
JPH09175966A (ja) 口腔用組成物
WO1995034274A1 (fr) Composition pour l'hygiene bucco-dentaire
JP2001172146A (ja) 口腔用組成物
WO1997045096A1 (fr) Compositions
EP0188313B1 (fr) Compositions d'hygiène buccale
HK1021505A (en) Compositions
HK1012286B (en) Compositions
GB2358584A (en) Oral care composition
MXPA97004193A (en) Oral compositions containing statistical compounds stabilizes
HK1004526B (en) Antimicorbial toothpaste
JPH01153621A (ja) 歯磨組成物
HK1002625B (en) Mouthwash for treating dentine hypersensitivity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010709

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 7/18 A, 7A 61K 7/16 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031202